34
Growth Score in past quarter
pts
Heat Score 34 in past quarter
-22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
447324
NanOlogy™ is a clinical-stage oncology company
- Gere diZerega: CEO
David Arthur: Chief Executive OfficerPast Role: Decoy Therapeutics, CEO
About the Company
NanOlogy™ is a clinical-stage oncology company formed in 2015 to develop a patented submicron particle technology to deliver high, sustained concentration of chemoimmunology agents directly to the site of disease.